PR PolyResearch
Join Free
NASDAQ

Abeona Therapeutics Inc. (ABEO)

♄ 709 Thanks from members

Abeona Therapeutics reported Q2 2026 financial results highlighting a 31% quarter-over-quarter growth in ZEVASKYN net revenue to $11.4 million, an expanding QTC network of seven nationwide sites, and $146.8 million in cash, despite swinging to a net loss.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →

Other Nasdaq Tickers

NASDAQ
GraniteShares 2x Long AAPL Daily ETF (AAPB)
NASDAQ
Apple Inc. (AAPL)
NASDAQ
Direxion Daily AAPL Bear 1X ETF (AAPD)
NASDAQ
Ascentage Pharma Group International - American Depository Shares (AAPG)
NASDAQ
Direxion Daily AAPL Bull 2X ETF (AAPU)
NASDAQ
Rocket Pharmaceuticals, Inc. - Warrant (RCKTW)